Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2441 to 2450 of 2579 total matches.
New Ways To Scan The Myocardium
The Medical Letter on Drugs and Therapeutics • Sep 20, 1991 (Issue 853)
, 1990), major
adverse events have occurred in less than 1% of patients, but about half of all patients ...
Myocardial images produced by injections of radioactive thallium chloride (201Tl), usually during exercise, have been used for many years for diagnosis of coronary artery disease (Medical Letter, 21:49, 1979). Recently, some new techniques and radiopharmaceuticals have become available for myocardial imaging.
Tadalafil (Adcirca) for Pulmonary Arterial Hypertension
The Medical Letter on Drugs and Therapeutics • Nov 02, 2009 (Issue 1324)
hypertension (PAH). Tadalafil is also marketed
as Cialis for treatment of erectile dysfunction.
1
DRUGS ...
The FDA has approved use of tadalafil (Adcirca - Lilly/United Therapeutics) for treatment of pulmonary arterial hypertension (PAH).
Preservation of Ovarian Function During Chemotherapy
The Medical Letter on Drugs and Therapeutics • Jun 28, 2010 (Issue 1341)
counseling followed by appropriate action may prevent
some of these undesirable consequences.
1 ...
Chemotherapy can result in premature menopause and infertility in young women. Pretreatment fertility
counseling followed by appropriate action may prevent some of these undesirable consequences.
Drugs for Ovulation Induction
The Medical Letter on Drugs and Therapeutics • Oct 31, 2011 (Issue 1376)
ovulation.
Fertilization usually occurs 24-36 hours after ovulation.
Table 1. Some Drugs for Ovulation ...
Infertility occurs in about 15% of couples. About one-third
of cases are due to problems with ovulation or other
female factors, another third are due to a male infertility
factor, and the remaining third are unexplained. In older
women, unexplained infertility is probably caused by
diminished quality and quantity of oocytes. The first
approach to treatment of female-factor infertility generally
is the use of drugs that stimulate oocyte production.
Bone Morphogenetic Protein (Infuse Bone Graft)
The Medical Letter on Drugs and Therapeutics • Dec 14, 2009 (Issue 1327)
to form trabecular
bone.
1
Bone formation begins on the outside of the
implanted collagen sponges ...
Harvesting of autogenous bone, most commonly from the iliac crest, for use as the interbody graft in spinal fusion procedures has been standard practice, but is associated with a high rate of morbidity, including graft site pain, infection, fracture, bleeding and damage to the femoral nerve. Use of recombinant human bone morphogenetic protein (rhBMP-2; Infuse Bone Graft - Medtronic) was first approved by the FDA in 2002 for single-level anterior lumbar spinal fusion in adults with degenerative disc disease who had not responded to at least 6 months of nonoperative treatment. Now it has also...
Clarification: Vitamin E
The Medical Letter on Drugs and Therapeutics • Mar 19, 2012 (Issue 1386)
, has any biological importance is
unclear.2
1. Who should take vitamin supplements? Med Lett Drugs Ther ...
The recent Medical Letter article on vitamin supplements1 included 2 sentences on vitamin E that could be misleading. "Vitamin E in food, which is mostly gamma-tocopherol, acts as an antioxidant. Vitamin E in supplements is mostly alpha-tocopherol, which may block the anti-oxidant effect of gamma-tocopherol and may have a pro-oxidant effect in vivo."Gamma-tocopherol is the most common form of vitamin E in the North American diet, and supplements are mostly alpha-tocopherol, which can, under some conditions, have a pro-oxidant effect. However, there is no evidence that taking supplements can...
In Brief: Ponatinib (Iclusig) Returns
The Medical Letter on Drugs and Therapeutics • Jan 20, 2014 (Issue 1434)
kinase inhibitor is indicated,”
presumably because of resistance or intolerance.
1. In brief: ponatinib ...
The October 2013 suspension of marketing and sales of ponatinib (Iclusig – Ariad) for treatment of leukemia1 has been lifted by the FDA, and the drug is expected to return to the market this month with narrower indications and heightened safety warnings.2 The reason for its suspension was a high incidence of thrombotic events, some of them fatal. The new indications limit use of the drug to patients with T315I-positive disease and those "for whom no other tyrosine kinase inhibitor is indicated," presumably because of resistance or intolerance.1. In brief: ponatinib (Iclusig) marketing and...
Table: Amyloid-Directed Antibodies for Alzheimer's Disease (online only)
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024 (Issue 1708)
Administration IV infusion over 30 minutes once every 4 weeks IV infusion over 1 hour once every 2 weeks; after ...
View the Table: Amyloid-Directed Antibodies for Alzheimer's Disease
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-2 doi:10.58347/tml.2024.1708e | Show Introduction Hide Introduction
Treatment of Heat Injury
The Medical Letter on Drugs and Therapeutics • Jul 13, 1990 (Issue 822)
or omission. Copyright 1988-2002. The Medical Letter, Inc.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB ...
Summer heat waves cause thousands of cases of heat-related illness in the USA each year and hundreds of heat-related deaths, especially among the elderly. A few principles may be helpful in preventing and treating heat injury.
Soft Contact Lenses
The Medical Letter on Drugs and Therapeutics • Jul 27, 1990 (Issue 823)
. The Medical Letter, Inc.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com ...
Soft contact lenses have been in use for more than 20 years. Since the last Medical Letter review (vol. 24, page 109, 1982), new products have been developed, and some problems have emerged.